Boston Scientific Corporation vs VF Corp — how do they compare? Boston Scientific Corporation trades at $51.07 (market cap $74.19B), while VF Corp trades at $14.79 (market cap $5.81B). The key difference: Boston Scientific Corporation is far larger — about 12.8× VF Corp's market cap, and VF Corp pays a 2.44% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | VFC | |
|---|---|---|
Market Cap | $74.19B | $5.81B |
Sector | Health | Consumer Cyclical |
52-Week High | $108.14 | $21.55 |
52-Week Low | $42.63 | $12.21 |
Enterprise Value | $86.27B | $10.09B |
Dividend Yield | — | 2.44% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.
Read more on VFC →